Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00338247

Public ClinicalTrials.gov record NCT00338247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 15, 2026, 12:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects With ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will provide pre-approval drug access to lapatinib, in combination with capecitabine, to patients whose breast cancer had progressed on other therapies

Study identification

NCT ID
NCT00338247
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Novartis
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Apr 5, 2016

2006 – 2015

United States locations

U.S. sites
159
U.S. states
43
U.S. cities
138
Facility City State ZIP Site status
Novartis Investigative Site Huntsville Alabama 35805
Novartis Investigative Site Anchorage Alaska 99508
Novartis Investigative Site Glendale Arizona 85304
Novartis Investigative Site Fayetteville Arkansas 72703
Novartis Investigative Site Little Rock Arkansas 72205
Novartis Investigative Site Bellflower California 90706
Novartis Investigative Site Burbank California 91505-4866
Novartis Investigative Site Gilroy California 95020
Novartis Investigative Site Long Beach California 90806
Novartis Investigative Site Long Beach California 90813
Novartis Investigative Site Newport Beach California 92663
Novartis Investigative Site San Diego California 92123
Novartis Investigative Site San Francisco California 94115-1710
Novartis Investigative Site Santa Rosa California 95403-1757
Novartis Investigative Site Stockton California 95204
Novartis Investigative Site Aurora Colorado 80010
Novartis Investigative Site Boulder Colorado 80304
Novartis Investigative Site Lafayette Colorado 80026
Novartis Investigative Site Hartford Connecticut 06105
Novartis Investigative Site Manchester Connecticut 06040
Novartis Investigative Site New Havey Connecticut 06511
Novartis Investigative Site Norwich Connecticut 06360
Novartis Investigative Site Washington D.C. District of Columbia 20007
Novartis Investigative Site Fort Lauderdale Florida 33328
Novartis Investigative Site Fort Myers Florida 33916
Novartis Investigative Site Fort Walton Beach Florida 32547
Novartis Investigative Site Gainesville Florida 32605
Novartis Investigative Site Hollywood Florida 33021
Novartis Investigative Site Jacksonville Florida 32256
Novartis Investigative Site Miami Florida 33133
Novartis Investigative Site Orlando Florida 32804
Novartis Investigative Site Orlando Florida 32806
Novartis Investigative Site Tampa Florida 33607
Novartis Investigative Site Augusta Georgia 30901
Novartis Investigative Site Brunswick Georgia 31525
Novartis Investigative Site Macon Georgia 31201
Novartis Investigative Site Marietta Georgia 30060
Novartis Investigative Site Tucker Georgia 30084
Novartis Investigative Site Honolulu Hawaii 96813
Novartis Investigative Site Boise Idaho 83712
Novartis Investigative Site Chicago Illinois 60637
Novartis Investigative Site Decatur Illinois 62526
Novartis Investigative Site Galesburg Illinois 61401
Novartis Investigative Site Highland Park Illinois 60035
Novartis Investigative Site Joliet Illinois 60435
Novartis Investigative Site Peoria Illinois 61615
Novartis Investigative Site Zion Illinois 60099
Novartis Investigative Site Indianapolis Indiana 46202
Novartis Investigative Site Bettendorf Iowa 52722
Novartis Investigative Site Cedar Rapids Iowa 52403
Novartis Investigative Site Council Bluffs Iowa 51503
Novartis Investigative Site Sioux City Iowa 51101-1733
Novartis Investigative Site Waterloo Iowa 50702
Novartis Investigative Site Baton Rouge Louisiana 70809
Novartis Investigative Site Metairie Louisiana 70006
Novartis Investigative Site Portland Maine 04101
Novartis Investigative Site Scarborough Maine 04074
Novartis Investigative Site Waterville Maine 04901
Novartis Investigative Site Baltimore Maryland 21231-1000
Novartis Investigative Site Baltimore Maryland 21237
Novartis Investigative Site Chevy Chase Maryland 20815
Novartis Investigative Site Frederick Maryland 21701
Novartis Investigative Site Boston Massachusetts 02111
Novartis Investigative Site Boston Massachusetts 02118
Novartis Investigative Site Fall River Massachusetts 02721
Novartis Investigative Site Peabody Massachusetts 01960
Novartis Investigative Site Ann Arbor Michigan 48106
Novartis Investigative Site Detroit Michigan 48202
Novartis Investigative Site Royal Oak Michigan 48073
Novartis Investigative Site Troy Michigan 48085
Novartis Investigative Site Duluth Minnesota 55802
Novartis Investigative Site Jackson Mississippi 39202
Novartis Investigative Site Columbia Missouri 65201
Novartis Investigative Site Kalamazoo Missouri 49007
Novartis Investigative Site Kansas City Missouri 64118
Novartis Investigative Site Springfield Missouri 65807
Novartis Investigative Site St Louis Missouri 63110
Novartis Investigative Site St Louis Missouri 63141
Novartis Investigative Site Billings Montana 59101
Novartis Investigative Site Great Falls Montana 59405
Novartis Investigative Site Grand Island Nebraska 68803
Novartis Investigative Site Lincoln Nebraska 68510
Novartis Investigative Site North Platte Nebraska 69103
Novartis Investigative Site Omaha Nebraska 68114
Novartis Investigative Site Omaha Nebraska 68124-2346
Novartis Investigative Site Las Vegas Nevada 89102
Novartis Investigative Site Exeter New Hampshire 03833
Novartis Investigative Site Flemington New Jersey 08822
Novartis Investigative Site Freehold New Jersey 07728
Novartis Investigative Site Little Silver New Jersey 07739
Novartis Investigative Site Livingston New Jersey 07039
Novartis Investigative Site Mountain Lakes New Jersey 07046
Novartis Investigative Site Newark New Jersey 07112
Novartis Investigative Site Buffalo New York 14221
Novartis Investigative Site Buffalo New York 14263
Novartis Investigative Site East Setauket New York 11733
Novartis Investigative Site East Syracuse New York 13057
Novartis Investigative Site Fresh Meadows New York 11366
Novartis Investigative Site Glens Falls New York 12801
Novartis Investigative Site New York New York 10003
Novartis Investigative Site New York New York 10011
Novartis Investigative Site New York New York 10016
Novartis Investigative Site New York New York 10065
Novartis Investigative Site Asheville North Carolina 28816
Novartis Investigative Site Charlotte North Carolina 28203
Novartis Investigative Site Charlotte North Carolina 28204
Novartis Investigative Site Fayetteville North Carolina 28304
Novartis Investigative Site Greensboro North Carolina 27403
Novartis Investigative Site Bismarck North Dakota 58501
Novartis Investigative Site Fargo North Dakota 58122
Novartis Investigative Site Cincinnati Ohio 45219
Novartis Investigative Site Cincinnati Ohio 45242
Novartis Investigative Site Cleveland Ohio 44106
Novartis Investigative Site Columbus Ohio 39705
Novartis Investigative Site Columbus Ohio 43210
Novartis Investigative Site Sandusky Ohio 44870
Novartis Investigative Site Oklahoma City Oklahoma 73109
Novartis Investigative Site Tulsa Oklahoma 74104
Novartis Investigative Site Tulsa Oklahoma 74133
Novartis Investigative Site Klamath Falls Oregon 97601
Novartis Investigative Site Portland Oregon 97213
Novartis Investigative Site Drexel Hill Pennsylvania 19026
Novartis Investigative Site Philadelphia Pennsylvania 19104
Novartis Investigative Site Philadelphia Pennsylvania 19106
Novartis Investigative Site Philadelphia Pennsylvania 19111
Novartis Investigative Site Pittsburgh Pennsylvania 15212-4772
Novartis Investigative Site Pittsburgh Pennsylvania 15213
Novartis Investigative Site Pottstown Pennsylvania 19464
Novartis Investigative Site Sayre Pennsylvania 18840
Novartis Investigative Site State College Pennsylvania 16803
Novartis Investigative Site Charleston South Carolina 29403
Novartis Investigative Site Columbia South Carolina 29210
Novartis Investigative Site Florence South Carolina 29506
Novartis Investigative Site Mt. Pleasant South Carolina 29464
Novartis Investigative Site Knoxville Tennessee 37916
Novartis Investigative Site Memphis Tennessee 38120
Novartis Investigative Site Nashville Tennessee 37203
Novartis Investigative Site Arlington Texas 76012
Novartis Investigative Site Austin Texas 78731
Novartis Investigative Site Austin Texas 78759
Novartis Investigative Site Dallas Texas 75230
Novartis Investigative Site Dallas Texas 75246
Novartis Investigative Site El Paso Texas 79912
Novartis Investigative Site Houston Texas 77030
Novartis Investigative Site Houston Texas 77230-1439
Novartis Investigative Site San Antonio Texas 78207
Novartis Investigative Site Salt Lake City Utah 84112-5550
Novartis Investigative Site Fairfax Virginia 22031
Novartis Investigative Site Richmond Virginia 23230
Novartis Investigative Site Richmond Virginia 23294
Novartis Investigative Site Kennewick Washington 99336
Novartis Investigative Site Mount Vernon Washington 98273
Novartis Investigative Site Seattle Washington 98112
Novartis Investigative Site Tacoma Washington 98405
Novartis Investigative Site Walla Walla Washington 99362
Novartis Investigative Site Morgantown West Virginia 26506
Novartis Investigative Site Green Bay Wisconsin 54311
Novartis Investigative Site La Crosse Wisconsin 54601
Novartis Investigative Site Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 294 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00338247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2016 · Synced Sep 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00338247 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →